TransMedics Group, Inc. Share Price

TransMedics Group, Inc. Share Price

NASDAQ: TMDX | Mid Cap
$65.99
-$1.22 (-1.82%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

TransMedics Group, Inc. Stock Performance

Open
$66.69
Prev. Close
$67.21
Circuit Range
N/A
Day Range
$64.73 - $66.87
Year Range
$60.17 - $155.67
Volume
52,182
Average Traded
$65.81

TransMedics Group, Inc. Share Price Today

As of 2 November 2026, TransMedics Group, Inc.'s share price is $65.99. The stock opened at $66.69, compared to its previous close of $67.21. During today's trading session, TransMedics Group, Inc.'s share price traded between $64.73 and $66.87, with an average price of $65.80. Over the past 52 weeks, the stock has recorded a high of $155.67 and a low of $60.17. In terms of performance, TransMedics Group, Inc.'s share price has declined by 34.47% over the last six months and is down 49.82% on a year-on-year basis.

TransMedics Group, Inc. Share Price Chart

Line chart of the TransMedics Group, Inc. price trend over the selected period. The price fell overall, ranging from 64.73 to 66.96, ending at 65.99.
$64.73$66.87
L
Show Current Price
H

TransMedics Group, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.24B
PE Ratio (TTM)
15.08
Dividend Yield
0.00%
EPS (TTM)
$4.37
Revenue (TTM)
$605.49B
Return On Equity (TTM)
29.28%
Profit Margin
31.43%
Debt to Equity
1.66
Quarterly Earnings Growth YoY
-39.64%

TransMedics Group, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$143.82$160.76$173.93$189.95
Net Profit$24.32$105.38$7.32$14.68
Net Profit Margin16.91%65.55%4.21%7.73%
Income ChangeN/A333.31%-93.05%100.55%

TransMedics Group, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$93.46$241.62$441.54$605.49
Net Profit-$36.23-$25.03$35.46$190.29
Net Profit Margin-38.77%-10.36%8.03%31.43%
Income ChangeN/A30.91%241.67%436.63%

About TransMedics Group, Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

TransMedics Group, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$83.78
$65.94
-21.21%
Sep 2026
$84.72
$83.69
-8.80%
Aug 2026
$79.96
$91.77
+19.91%
Jul 2026
$69.00
$76.53
+15.27%
Jun 2026
$65.76
$66.39
-1.13%
May 2026
$99.98
$67.15
-33.32%
Apr 2026
$101.92
$100.70
+1.33%
Mar 2026
$139.50
$99.38
-31.59%
Feb 2026
$133.02
$145.27
+8.38%
Jan 2026
$124.04
$134.04
+10.15%
Dec 2025
$143.20
$121.69
-16.64%
Nov 2025
$128.68
$145.99
+11.01%

TMDX Share Price FAQs